Symposia

JAK inhibitors in clinical practice:
Updates from the clinic and real world


Symposium at the IBD Nordic Conference, Quality Hotel View, Malmö, Sweden
November 24th 2022, 09:00 AM CET

The Event

Disclaimer: This page is for Health Care Professionals only.

JAK inhibitors in clinical practice
During the IBD Nordic conference Galapagos invites you to a morning symposium with guest speakers from the Nordic countries. The event will be accessible remotely as well.

Symposium 

If you are not able to attend the symposium, please use this link to watch the symposium online: 

Speakers

Bjørn Moum 
Professor of Medicine and Gastroenterology, Oslo University, Norway

Bjørn is Prof.em. at the University of Oslo, and a senior research consultant at Østfold Hospital Trust, Norway. Bjørn has been President of the Norwegian Gastroenterology Association and a Board member for 12 years. He is a personal elected member of the International Organization for IBD (IOIBD) and has been a National Representative Member of the European Crohn’s and Colitis Organization (ECCO).


Jan Marsal
Lund University and Skåne University Hospital, Sweden

Jan is a Senior Consultant in Gastroenterology/Hepatology and Internal Medicine focusing on Inflammatory Bowel Diseases (IBD) at Skåne University Hospital and Lund University in Lund and Malmö, Sweden. Jan is also as an Associate Professor leading a research group of PhD-students, exploring various aspects of IBD and currently chairs the Therapy Group of SOIBD (Swedish Organization for the study of IBD).


Johan Burisch 
Hvidovre Hospital, and Copenhagen Center for Inflammatory Bowel Disease, Denmark

Johan is a Gastroenterologist at Hvidovre Hospital as well as the Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults. Johan specializes in epidemiological studies on natural disease course and pattern recognition, studies of the prognosis of IBD as well as eHealth solutions for patients with IBD.


Johan Burisch
 


Welcome and introduction


Jan Marsal
 


JAK inhibitors in IBD & Mechanism of Action


Jan Marsal
 


Clinical trial data – SELECTION Study


Bjørn Moum
 


Clinical practice & real-world experience

Bjørn Moum
Jan Marsal 
Johan Burisch

 

Q&A and  discussion